To evaluate GrB activity and the response to vaccination as a predictor of risk for influenza illness, we determined the likelihood of LCII relative to the standardized pre- and 4-weeks post-vaccination activity levels and the fold-change in ex vivo GrB activity with vaccination. This evidence concerns the gene GZMB and influenza.